The agency in brief
Supporting research to prevent, understand and treat emerging infectious diseases
Publié le 24 February 2023 (dernière mise à jour le 30 September 2025)
Main points
ANRS Emerging infectious diseases (ANRS MIE) is an independent agency of Inserm that facilitates, evaluates, coordinates and funds research into HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging and re-emerging infectious diseases. The agency prepares responses to the scientific challenges posed by emerging diseases and ensures their deployment in times of crisis.
A central role in infectious disease research for over 35 years
The ANRS Emerging Infectious diseases (ANRS MIE) was created in 2021 by the merger of two entities: the national AIDS research agency (ANRS) and the Inserm Research and Action Targeting Emerging Infectious Diseases (REACting) consortium. It is the result of a natural and necessary evolution of the historical ANRS, an institution that has contributed to major advances in the fight against HIV/AIDS and viral hepatitis.
ANRS MIE is an agency for facilitation, coordination, evaluation and funding, with the ambition to be a pillar of research in France and worldwide on HIV/AIDS, viral hepatitis, sexually transmitted infections, tuberculosis and emerging infectious diseases. Discover all the diseases and pathogens focused on by ANRS MIE
